Published in Catheter Cardiovasc Interv on February 01, 1999
Iatrogenic coronary artery dissections extending into and involving the aortic root. Catheter Cardiovasc Interv (2000) 2.94
Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation (1988) 1.24
QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab (1987) 1.16
Long-term follow-up of coronary artery occlusion secondary to blunt chest trauma. Am Heart J (1987) 1.16
Nifedipine-associated acute psychosis. Am J Med (1986) 1.13
Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol (1986) 0.89
Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol (1991) 0.89
Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care (1986) 0.88
Failed direct coronary angioplasty for acute myocardial infarction: in-hospital outcome and predictors of death. J Am Coll Cardiol (1993) 0.85
Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol (1991) 0.82
Prediction of death and neurologic outcome in the emergency department in out-of-hospital cardiac arrest survivors. Am J Cardiol (1998) 0.79
Delayed progression or regression of coronary atherosclerosis with intensive risk factor modification. Effects of diet, drugs, and exercise. Sports Med (1996) 0.78
Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab (1986) 0.78
How does the fairer sex fare after PTCA? Cathet Cardiovasc Diagn (1996) 0.75
Infarct artery stents: the first year. Cathet Cardiovasc Diagn (1997) 0.75
To air is human, to prevent is divine. Cathet Cardiovasc Diagn (1995) 0.75
No-reflow no more? Cathet Cardiovasc Diagn (1996) 0.75
Infarct angioplasty: the hole story. Cathet Cardiovasc Diagn (1997) 0.75
Maximizing your guide-given talents. Cathet Cardiovasc Diagn (1996) 0.75
Confusion about perfusion. Cathet Cardiovasc Diagn (1997) 0.75
Why we get out of bed to do infarct PTCA. Cathet Cardiovasc Diagn (1996) 0.75
Can we defend the bill of rights? Cathet Cardiovasc Diagn (1996) 0.75
Collateral injury by total occlusion angioplasty: biting the hand that feeds us. Cathet Cardiovasc Diagn (1995) 0.75
There's no business like flow business! Cathet Cardiovasc Diagn (1996) 0.75
Catheter debris: it's a jungle in there! Catheter Cardiovasc Interv (2000) 0.75
Coronary stents: increasing options and indications. Cathet Cardiovasc Diagn (1998) 0.75
Culprit vessel angioplasty: it's a small world after all. Cathet Cardiovasc Diagn (1996) 0.75
Arterial sealing: we keep plugging away. Cathet Cardiovasc Diagn (1998) 0.75
Stents for infarcts: the missing link? Catheter Cardiovasc Interv (2000) 0.75
The equivalence of antithrombolytic agents. Hosp Pract (Off Ed) (1992) 0.75
Options to heparin anticoagulation for cardiac interventions. Catheter Cardiovasc Interv (1999) 0.75
Preoperative cardiac evaluation. Assessing risk before noncardiac surgery. Postgrad Med (1995) 0.75
Plasma levels of immunoreactive atrial natriuretic hormone in patients with diabetes mellitus. Regul Pept (1986) 0.75
Friction-free stenting. Cathet Cardiovasc Diagn (1997) 0.75
Evidence that arginine vasotocin inhibits human chorionic gonadotropin and cyclic adenosine 3',5' monophosphate stimulated ovarian steroidogenesis. Biochem Biophys Res Commun (1981) 0.75
The infusion delivery time of the flow-directed pulmonary artery catheter: clinical implications. Heart Lung (1983) 0.75
Validation of a decision support tool for the evaluation of cardiac arrest victims. Clin Cardiol (1998) 0.75
Direct infarct angioplasty: therapy for the 1990's. J Invasive Cardiol (1992) 0.75